Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
06 June 2019 | Story Valentino Ndaba | Photo Rian Horn
Solar Panels at UFS Qwaqwa Campus
Revolutionising electricity with sun power: Solar panels at the Qwaqwa Campus.
Over the past few years the University of the Free State (UFS) has been planting panels, now the time has come to reap. Solar farms produced a return on investment in the form of R1.4 million in savings as a result of photovoltaics (PV) between January and March 2019. Nicolaas Esterhuysen, an electrical engineer at the Department of University Estates also reported a 2.34% decline in electricity usage between 2013 and 2018. 

Solar panels are the future 

According to Esterhuysen, the solution to a power crisis lies in “either becoming more energy efficient or generating our own at a cheaper cost”. All campuses have managed to save a total of R5.4 million in 2018 through producing our own power (solar PV) and actively managing the instantaneous load demand with building management system (BMS) software.

Overall, ground-mounted PV installations at all campuses contribute 2609 kilowattpeak (kWp) under standard conditions. The Bloemfontein Campus accounts for 979kWp of that amount while the South Campus generates 762kWp, with the Qwaqwa Campus producing 748kWp, and the Paradys experimental farm bringing in 120kWp to the grand total (to be commissioned June 2019).

Rooftop PVs generate electricity through the 80kWp Muller Potgieter Building, the 255kWp Bloemfontein Campus computer lab, the 35kWp Qwaqwa Campus computer lab, 135kWp Qwaqwa Campus Mandela Hall, and 416kWp Thakaneng Bridge panels. This is a total of 921kWp. 

Winter is coming with tariff terrors 

A 15.63% electricity tariff increase is projected this year in light of the annual winter adjustments commissioned by Eskom and Centlec. To gear up for the associated spike in power use over this season, University Estates advises the Kovsie community to use energy efficiently. “Think twice before switching on the heating and make sure to switch it off when you leave the office,” advises Esterhuysen.

In addition to generating electricity, saving initiatives such as implementing light-emitting diode (LED) lighting with motion sensors and actively managing demand at peak times have been implemented.

What’s next?

The next step is to rethink dated mechanical installations that are used to heat some of our older buildings. Replacing similar installations across all of the campuses are some of the ways the university intends to escalate energy efficient in future. 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 
Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept